Navigation Links
BioRestorative Therapies Signs License Agreement for Stem Cell Disc/Spine Procedure
Date:1/31/2012

>About BioRestorative Therapies, Inc.
BioRestorative Therapies, Inc.'s goal is to become a medical center of excellence using cell and tissue protocols, primarily involving a patient's own (autologous) adult stem cells (non-embryonic), allowing patients to undergo cellular-based treatments. In June 2011, the Company launched a technology that involves the use of a brown fat cell-based therapeutic/aesthetic program, known as the ThermoStem™ Program.  The ThermoStem™ Program will focus on treatments for obesity, weight loss, diabetes, hypertension, other metabolic disorders and cardiac deficiencies and will involve the study of stem cells, several genes, proteins and/or mechanisms that are related to these diseases and disorders.  As more and more cellular therapies become standard of care, the Company believes its strength will be its focus on the unity of medical and scientific explanations for clinical procedures and outcomes for future personal medical applications.  The Company also plans to offer and sell facial creams and products under the Stem Pearls™ brand.

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events or results to differ materially from those projected in the forward-looking statements as a result of various factors and other risks, including those set forth in the Company's Form 10, as amended, filed with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and
'/>"/>

SOURCE BioRestorative Therapies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. BioRestorative Therapies Signs License Agreement With University of Utah to Obtain Adipose (Fat) Tissue for its ThermoStem Program to Treat Obesity and Metabolic Disorders
2. Genetic and Proteomic Advances Pave the Way for Next-Generation Leukemia Therapies
3. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Combination Study of MM-121 and Multiple Anticancer Therapies in Patients with Advanced Solid Tumors
4. U.S. Food and Drug Administration (FDA) Delays Review of Takedas Investigational Type 2 Diabetes Therapies, Alogliptin and Alogliptin/Pioglitazone
5. Lilly Provides Additional Funding to Infectious Disease Research Institute to Identify New Tuberculosis Therapies
6. OncoSec and Serametrix Collaborate to Identify Potential Biomarkers to Enhance Skin Cancer Immune Therapies
7. B. Braun Renal Therapies Division Announces Enhanced Offerings for Hemodialysis System
8. Takeda Announces PDUFA Action Date for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination Alogliptin/Pioglitazone
9. OncoSec Medical to Attend 6th Annual Fire, Ice and Beyond: The Future of Ablation Therapies Conference
10. CSA Medical Appoints Wendelin Maners VP of Emerging Therapies
11. Californians Recognized For Role In Helping Rare Disease Patients Who Need Lifesaving Therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015 Gem Pharmaceuticals announced today that the initial ... the Company,s Phase 2 clinical trial.  This open-label study ... compound, GPX-150 (an investigational medication), in approximately 30 adults ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
(Date:1/23/2015)... CHENGDU, China , Jan. 23, 2015 Tianyin ... pharmaceutical company that specializes in the development and sale ... branded generics and active pharmaceutical ingredients (API) today announced ... Facility (JCM) API operation. 1. Following the ...
(Date:1/22/2015)...  BiOptix is pleased to announce the appointment of Dr. ... and Biochemistry. Scott joins the company after previous scientific leadership ... the course of his nearly 20 year career in ... nationally recognized thought leader in the biosensor field and ...
Breaking Medicine Technology:Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2
... Bayer HealthCare Pharmaceuticals today launched FactorTrack™, the first customizable mobile application ... interactive mobile application that helps make it easier to track and ... , , ... locations of bleeds.  It allows people with hemophilia A to customize ...
... ORLANDO, Fla. , June 28 Poster 16LB -- Late-breaking ... of the American Diabetes Association (ADA) showed that once-daily Victoza ® in ... and fasting plasma glucose (FPG) than Januvia ® plus metformin at 52 ... Key findings from the study ...
Cached Medicine Technology:Bayer HealthCare Introduces First Mobile Application to Assist Hemophilia A Patients in Managing Their Treatment 2Bayer HealthCare Introduces First Mobile Application to Assist Hemophilia A Patients in Managing Their Treatment 3New Data Demonstrates Victoza® (liraglutide [rDNA] injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at One Year 2New Data Demonstrates Victoza® (liraglutide [rDNA] injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at One Year 3New Data Demonstrates Victoza® (liraglutide [rDNA] injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at One Year 4New Data Demonstrates Victoza® (liraglutide [rDNA] injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at One Year 5New Data Demonstrates Victoza® (liraglutide [rDNA] injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at One Year 6New Data Demonstrates Victoza® (liraglutide [rDNA] injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at One Year 7
(Date:1/22/2015)... January 22, 2015 The City of West Hollywood ... a.m., to commemorate the 42nd anniversary of the Supreme Court decision ... “It’s been 42 years since the Roe vs. Wade decision and ... as present as ever,” said City of West Hollywood Councilmember Abbe ...
(Date:1/22/2015)... VogueQueen is a seasoned and trusted leader who ... are thrilled to have it lead the wedding dress industry ... of prom dresses for the global market. , “The CEO ... and he focuses on continuing the goal of operational excellence ...
(Date:1/22/2015)... the premier women’s dress supplier, has recently released its ... of AngelWeddingDress.com to find more details. , Many ... a bridal party. AngelWeddingDress offers a variety of gorgeous ... wedding dresses are specially designed for 2015. , AngelWeddingDress ...
(Date:1/22/2015)... 22, 2015 Thousand of GranuFlo lawsuits ... recalled its GranuFlo and NaturaLyte dialysis concentrates continue to ... U.S. District Court, District of Massachusetts, Bernstein Liebhard LLP ... Court has remanded a case filed by the state ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Joan Lunden, ... keynote speaker at the upcoming 32nd Annual Miami ... Physicians’ Education Resource®, LLC (PER®) , shares that ... have gone undetected if she had not followed up ...
Breaking Medicine News(10 mins):Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6
... By Steven Reinberg HealthDay Reporter , TUESDAY, May ... lives of people with breast and colon cancer, a new ... cancers, but there is no substantial evidence to make that ... that says physical activity after a cancer diagnosis is generally ...
... Everyone knows teen behavior is highly influenced by their friends, but ... or not a teen drinks alcohol or uses drugs. If ... drug or alcohol use, or worse, condone it, that may make ... "Among friendship groups with ,good parents, there,s a synergistic effect ...
... News) -- Incentives such as gift cards, T-shirts and coupons ... Researchers analyzed data from 14,000 blood drives involving 500,000 ... field experiment. They found that incentives led to a 15 ... taking part in blood drives. Incentives did not change ...
... root cause of rheumatoid arthritis has been a difficult ... to multiple culprits in our immune system, with contradictory ... announce that it takes a diverse array of regulatory ... to prevent the immune system from generating the tissue-specific ...
... new weapon in the fight against malaria , Over ... the World Health Organization, an estimated 655,000 people died from ... Plasmodium , which is transmitted to humans through mosquito bites. ... new tools to prevent new infections. Wesley Van Voorhis at ...
... is pleased to announce that the winner of the 2012 ... ECNP Media Award recognises outstanding contributions to destigmatising disorders of ... will be presented annually, and is accompanied by a prize ... to celebrate the achievements of those who promote a better ...
Cached Medicine News:Health News:Exercise May Boost Survival in Breast, Colon Cancer Patients 2Health News:Exercise May Boost Survival in Breast, Colon Cancer Patients 3Health News:Friends' Parents Can Sway Teens' Odds for Drinking, Smoking 2Health News:Regulatory immune cell diversity tempers autoimmunity in rheumatoid arthritis 2Health News:Regulatory immune cell diversity tempers autoimmunity in rheumatoid arthritis 3Health News:JCI early table of contents for May 8, 2012 2Health News:JCI early table of contents for May 8, 2012 3Health News:JCI early table of contents for May 8, 2012 4Health News:JCI early table of contents for May 8, 2012 5Health News:JCI early table of contents for May 8, 2012 6Health News:JCI early table of contents for May 8, 2012 7Health News:The Science Media Centre, London, wins the 2012 ECNP Media Award 2
Rapid membrane-based immunogold assay for the qualitative detection of rotavirus antigen in human fecal specimens; aids in the diagnosis of acute gastroenteritis caused by rotavirus infection....
... Acolytes core technology relates to the ... enzyme found in all living cells. ... measured using bioluminescence. By coupling ... example via extraction using antibody-coated beads, Acolyte ...
... IDI-MRSA is the first diagnostic test cleared ... the direct detection of nasal colonization by methicillin ... PCR technology, IDI-MRSA test results are available in ... nasal swab, compared to other methods that require ...
... Endoscopy's Arthroscopic Shaver System is ... which provides aggressive tissue resection ... an arthroscopy. The new Formula™ ... with precision cutting to offer ...
Medicine Products: